L. Pellegrini

Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model

V. Torres, Xiaofang Wang, M. Constans, 2019, American Journal of Nephrology.

Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling

L. Pellegrini, B. Howell, L. Shoda, 2020, Pharmaceutical Research.

Improved chromosome level genome assembly of the Glanville fritillary butterfly (Melitaea cinxia) based on SMRT Sequencing and linkage map

P. Auvinen, P. Rastas, L. Paulin, 2020, bioRxiv.

Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells

L. Pellegrini, Annarita Di Mise, G. Tamma, 2019, International journal of molecular sciences.

Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling

L. Pellegrini, B. Howell, L. Shoda, 2020, Pharmaceutical Research.

Improved chromosome-level genome assembly of the Glanville fritillary butterfly (Melitaea cinxia) integrating Pacific Biosciences long reads and a high-density linkage map

P. Auvinen, P. Rastas, L. Paulin, 2022, GigaScience.

Pre‐clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease

V. Torres, Xiaofang Wang, L. Pellegrini, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.